CagriSema shows promise in Novo Nordisk’s phase 3 obesity trial
Bagsværd, Denmark- December 2024- Novo Nordisk announced headline results from REDEFINE 1, a phase 3 trial in the global REDEFINE programme. REDEFINE 1 is a 68-week... Read more.
Burjeel Holdings acquires 100% stake in Makkah’s specialist physiotherapy center
December 2024- Burjeel Holdings has announced the acquisition of a 100% stake in the Specialist Physiotherapy Center, a premier healthcare facility in Makkah, through... Read more.
Dubai Health ensures New Year’s Eve safety with comprehensive plan
Dubai, UAE- December 2024- As Dubai prepares to welcome the new year with grand celebrations, Dubai Health has prepared its comprehensive readiness plan to ensure... Read more.
KPJ Healthcare Clinches Triple HR Awards for Excellence in Human Capital
Kuala Lumpu – December 2024 – KPJ Healthcare Berhad has achieved a significant milestone in human capital excellence, securing three prestigious awards... Read more.
Cardinal Health Launches Routine Actinium-225 Production at Theranostics Center
DUBLIN, Ohio – December 2024 – Cardinal Health announced the start of weekly production of actinium-225 (Ac-225) through its Center for Theranostics Advancement... Read more.
Lauren Averett Byers Receives TAMEST O’Donnell Award for Lung Cancer Research
December 2024 – Lauren Averett Byers, M.D., professor of Thoracic/Head & Neck Medical Oncology at The University of Texas MD Anderson Cancer Center,... Read more.
Agilent Companion Diagnostic Assay PD-L1 IHC 28-8 pharmDx Receives European IVDR Certification
December 2024 – Agilent Technologies Inc. announced the issuing of a Class C companion diagnostic In Vitro Diagnostic Regulation (IVDR) certification for PD-L1... Read more.
FDA approves Bristol Myers Squibb’s Subcutaneous Opdivo Qvantig™ for various solid tumor indications
December 2024- Bristol Myers Squibb announced that the U.S. Food and Drug Administration (FDA) granted approval for Opdivo Qvantig™ (nivolumab and hyaluronidase-nvhy)... Read more.
Merck enters into exclusive global license agreement with Hansoh Pharma
December 2024- Merck, known as MSD outside of the United States and Canada, and Hansoh Pharma, a Chinese biopharmaceutical company, announced that they have entered... Read more.
UNM College of Nursing celebrates Fall 2024 award winners
December 2024- Three graduating University of New Mexico College of Nursing students were recognized with awards for their achievements at the Fall 2024 convocation,... Read more.
